Advertisement
Organisation › Details
OncXerna Therapeutics Inc.
OncXerna is a precision medicine company using an innovative RNA-expression based biomarker platform to predict patient responses to its targeted oncology therapeutic candidates. OncXerna is working to expand next-generation precision medicine to a larger group of cancer patients by leveraging the company’s Xerna™ platform to prospectively identify patients based on the dominant biology of their cancer. OncXerna’s approach pairs those patients with OncXerna’s clinical-stage therapeutic candidates and known mechanism of action that directly address these biologies, with the goal to substantially improve patient outcomes. The Xerna™ TME Panel uses proprietary RNA-based gene expression data and a machine learning-based algorithm to classify patients based on the interplay between angiogenic and immunogenic dominant biologies of the tumor microenvironment (TME), and has been developed as a clinical assay. The Xerna™ TME Panel is an investigational assay that has not been approved, and has not been demonstrated to be safe or effective for any use. *
Start | 2020-09-18 renamed | |
Group | OncXerna Therapeutics (Group) | |
Predecessor | Oncologie Inc. (US/CN) | |
Industry | drug development | |
Industry 2 | cancer drug | |
Person | Benjamin, Laura (Oncologie Inc 201802 CEO) | |
City | n. a. | |
Address record changed: 2021-08-10 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Qiagen N.V.. (8/9/21). "Press Release: Qiagen and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements". Hilden, Waltham, MA & Germantown, MD. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for OncXerna Therapeutics (Group)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top